Barclays lowered its price target on Molina Healthcare stock following an analyst report.
1 report, 1 independent
Updated Sep 5
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Barclays lowered its price target on Molina Healthcare stock following an analyst report.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Barclays
British bank
- QinetiQ carried out share purchases and arranged for a share buyback execution on the London Stock Exchange.
- Financial institutions provided ratings on multiple companies on July 8, 2026, including Goldman Sachs reiterating Tesla as neutral, Barclays initiating Toast as overweight, and Bank of America rating Nvidia as a buy.
-
Molina Healthcare
American managed care company
Nothing else this week.
Related events
- Market pressure due to cost trends is affecting major companies including UnitedHealth Group, Molina Healthcare, Abbott Laboratories, and Eli Lilly, as reported on Investopedia.
- Barclays dropped its target price on TIM Group stock, while Santander Group and Scotiabank raised their price objectives for the company.
- Analyst rating changes are affecting market perception, alongside filings made with the SEC regarding stock purchases for Barclays and Jan.
- Barclays cut its rating to underperform and lowered the price target for Montrose Environmental Group.
Coverage
Newest first; wire copies grouped- StockStoryWhy Molina Healthcare (MOH) Stock Is Falling Today Shares of healthcare insurance company Molina Healthcare (NYSE:MOH) fell 4.8% in the morning session after Barclays lowered its price target on the